Infection with Trypanosoma cruzi causes a generalised vasculitis of several
vascular beds. This vasculopathy is manifested by vasospasm, reduced blood
flow, focal ischaemia, platelet thrombi, increased platelet aggregation an
d elevated plasma levels of thromboxane A(2) and endothelin-1, In the myoca
rdium of infected mice, myonecrosis and a vasculitis of the aorta, coronary
artery, smaller myocardial vessels and the endocardial endothelium are obs
erved. Immunohistochemistry studies employing anti-endothelin-1 antibody re
vealed increased expression of endothelin-1, most intense in the endocardia
l and vascular endothelium. Elevated levels of mRNA for prepro endothelin-1
, endothelin converting enzyme and endothelin-1 were observed in the infect
ed myocardium. When T. cruzi-infected mice were treated with phosphoramidon
, an inhibitor of endothelin converting enzyme, there was a decrease in hea
rt size and severity of pathology. Mitogen-activated protein kinases and th
e transcription factor activator-protein-1 regulate the expression of endot
helin-1. Therefore, we examined the activation of mitogen-activated protein
kinases in the myocardium by T. cruzi. Western blot demonstrated an extrac
ellular signal regulated kinase. In addition, the activator-protein-1 DNA b
inding activity, as determined by electrophoretic mobility shift assay, was
increased. Increased expression of cyclins A and cyclin D1 was observed in
the myocardium, and immunohistochemistry studies revealed that interstitia
l cells and vascular and endocardial endothelial cells stained intensely wi
th antibodies to these cyclins. These data demonstrate that T. cruzi infect
ion of the myocardium activates extracellular signal regulated kinase, acti
vator-protein-1, endothelin-1, and cyclins. The activation of these pathway
s is likely to contribute to the pathogenesis of chagasic heart disease. Th
ese experimental observations suggest that the vasculature plays a role in
the pathogenesis of chagasic cardiomyopathy. Additionally, the identificati
on of these pathways provides possible targets for therapeutic intervention
s to ameliorate or prevent the development of cardiomyopathy during T, cruz
i infection. (C) 2001 Australian Society for Parasitalogy Inc. Published by
Elsevier Science Ltd. All rights reserved.